Serum potassium testing in diuretic-treated outpatients. A multivariate approach

Area of Science:

• Nephrology
• Clinical Pharmacology

Background:

• Chronic diuretic therapy is widely used but can cause electrolyte imbalances, particularly abnormal serum potassium concentrations.
• Hypokalemia and hyperkalemia are potential adverse effects requiring careful patient monitoring.

Purpose of the Study:

• To evaluate risk factors for abnormal serum potassium (K+) concentrations in outpatients receiving chronic diuretic therapy.
• To identify predictors of hypokalemia and hyperkalemia in this patient population.

Main Methods:

• Retrospective analysis of 5817 outpatients on chronic diuretic therapy.
• Logistic regression analysis to identify significant risk factors for abnormal serum potassium levels.

Main Results:

• Hypokalemia (K+ < 3.5 meq/L) occurred in 18.8% of patients; hyperkalemia (K+ > 5.5 meq/L) was rare (0.5%).
• Risk factors for hypokalemia included younger age, better health, hypertension, thiazide diuretic use, and prior hypokalemia.
• Risk factors for hyperkalemia included older age, heart/renal failure, and furosemide use.
• A regression model identified key predictors, stratifying patients into low-risk (9.4% hypokalemia) and high-risk (35% hypokalemia) groups.

Conclusions:

• Predictive models can effectively identify outpatients at high risk for hypokalemia on chronic diuretic therapy.
• This information can guide the frequency of serum potassium monitoring in individual patients.
• Targeted monitoring can optimize patient care and resource allocation.